市場調查報告書

呼吸道淨化系統的全球市場

Airway Clearance Systems

出版商 Global Industry Analysts, Inc. 商品編碼 956939
出版日期 內容資訊 英文 229 Pages
商品交期: 最快1-2個工作天內
價格
呼吸道淨化系統的全球市場 Airway Clearance Systems
出版日期: 2020年09月01日內容資訊: 英文 229 Pages
簡介

全球呼吸道淨化系統的市場規模在2020年∼2027年的分析期間中預計將以6.2%的年複合成長率增長,從2020年的5億2,210萬美元到2027年達到7億9,340萬美元。市場區隔之一的呼氣表面壓 (PEP) 部門在分析期間結束前預測將以5.9%的年率增長,達到4億1,430萬美元的規模。

本報告提供全球呼吸道淨化系統市場的相關調查,提供市場佔有率,趨勢和預測,成長要素,各地區的市場分析,競爭情形,主要企業的簡介等資訊。

調查對象企業範例

  • Electromed, Inc.
  • General Physiotherapy, Inc.
  • Hill-Rom Holdings, Inc.
  • Monaghan Medical Corporation
  • Philips Healthcare
  • Thayer Medical
  • Vortran Medical Technology

目錄

I. 簡介,調查手法 、 調查範圍

II. 摘要整理

  • 市場概要
    • 競爭的市場佔有率
    • 競爭的市場佔有率方案
    • Covid-19的影響和即將到來的全球景氣衰退
  • 主要企業
  • 趨勢與成長要素
  • 全球市場預測

III. 市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 其他地區

IV. 競爭

  • 企業簡介:46公司
目錄
Product Code: MCP10221

Global Airway Clearance Systems Market to Reach $793.4 Million by 2027

Amid the COVID-19 crisis, the global market for Airway Clearance Systems estimated at US$522.1 Million in the year 2020, is projected to reach a revised size of US$793.4 Million by 2027, growing at a CAGR of 6.2% over the analysis period 2020-2027. Positive Expiratory Pressure (PEP), one of the segments analyzed in the report, is projected to record a 5.9% CAGR and reach US$414.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Oscillatory Positive Expiratory Pressure (OPEP) segment is readjusted to a revised 6.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $154 Million, While China is Forecast to Grow at 5.8% CAGR

The Airway Clearance Systems market in the U.S. is estimated at US$154 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$139.6 Million by the year 2027 trailing a CAGR of 5.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 4.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Other Device Types Segment to Record 5.4% CAGR

In the global Other Device Types segment, USA, Canada, Japan, China and Europe will drive the 5.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$43.6 Million in the year 2020 will reach a projected size of US$63.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$91.5 Million by the year 2027.We bring years of research experience to this 9th edition of our report. The 229-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Electromed, Inc.
  • General Physiotherapy, Inc.
  • Hill-Rom Holdings, Inc.
  • Monaghan Medical Corporation
  • Philips Healthcare
  • Thayer Medical
  • Vortran Medical Technology

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Competitor Market Shares
    • Airway Clearance Systems Competitor Market Share Scenario Worldwide (in %): 2019 &
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Airway Clearance Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 2: World Historic Review for Airway Clearance Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 3: World 15-Year Perspective for Airway Clearance Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Positive Expiratory Pressure (PEP) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 5: World Historic Review for Positive Expiratory Pressure (PEP) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 6: World 15-Year Perspective for Positive Expiratory Pressure (PEP) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Oscillatory Positive Expiratory Pressure (OPEP) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 8: World Historic Review for Oscillatory Positive Expiratory Pressure (OPEP) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 9: World 15-Year Perspective for Oscillatory Positive Expiratory Pressure (OPEP) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 11: World Historic Review for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 12: World 15-Year Perspective for Other Device Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Cystic Fibrosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 14: World Historic Review for Cystic Fibrosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 15: World 15-Year Perspective for Cystic Fibrosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Chronic Bronchitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 17: World Historic Review for Chronic Bronchitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 18: World 15-Year Perspective for Chronic Bronchitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 20: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 21: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 23: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 24: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 26: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 27: World 15-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 29: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 30: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Airway Clearance Systems Market Share (in %) by Company: 2019 &
    • Market Analytics
    • TABLE 31: USA Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 32: USA Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 33: USA 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 34: USA Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 35: USA Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 36: USA 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 37: USA Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 38: USA Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 39: USA 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 40: Canada Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 41: Canada Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 42: Canada 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 43: Canada Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 44: Canada Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 45: Canada 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 46: Canada Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 47: Canada Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 48: Canada 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 49: Japan Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 50: Japan Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 51: Japan 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 52: Japan Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 53: Japan Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 54: Japan 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 55: Japan Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 56: Japan Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 57: Japan 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 58: China Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 59: China Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 60: China 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 61: China Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 62: China Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 63: China 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 64: China Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 65: China Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 66: China 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • EUROPE
    • Market Facts & Figures
    • European Airway Clearance Systems Market: Competitor Market Share Scenario (in %) for 2019 &
    • Market Analytics
    • TABLE 67: Europe Current & Future Analysis for Airway Clearance Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 68: Europe Historic Review for Airway Clearance Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 69: Europe 15-Year Perspective for Airway Clearance Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 70: Europe Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 71: Europe Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 72: Europe 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 73: Europe Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 74: Europe Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 75: Europe 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 76: Europe Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 77: Europe Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 78: Europe 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 79: France Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 80: France Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 81: France 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 82: France Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 83: France Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 84: France 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 85: France Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 86: France Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 87: France 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 88: Germany Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 89: Germany Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 90: Germany 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 91: Germany Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 92: Germany Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 93: Germany 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 94: Germany Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 95: Germany Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 96: Germany 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 97: Italy Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 98: Italy Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 99: Italy 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 100: Italy Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 101: Italy Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 102: Italy 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 103: Italy Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 104: Italy Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 105: Italy 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 106: UK Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 107: UK Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 108: UK 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 109: UK Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 110: UK Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 111: UK 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 112: UK Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 113: UK Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 114: UK 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 115: Rest of Europe Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 116: Rest of Europe Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 117: Rest of Europe 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 118: Rest of Europe Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 119: Rest of Europe Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 120: Rest of Europe 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 121: Rest of Europe Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 122: Rest of Europe Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 123: Rest of Europe 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 124: Asia-Pacific Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 125: Asia-Pacific Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 126: Asia-Pacific 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 127: Asia-Pacific Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 128: Asia-Pacific Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 129: Asia-Pacific 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 130: Asia-Pacific Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 131: Asia-Pacific Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 132: Asia-Pacific 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 133: Rest of World Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 134: Rest of World Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 135: Rest of World 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 136: Rest of World Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 137: Rest of World Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 138: Rest of World 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 139: Rest of World Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 140: Rest of World Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 141: Rest of World 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 46